MARKET

KTRA

KTRA

Kintara Therapeutics Inc
NASDAQ
4.360
-0.010
-0.23%
After Hours: 4.640 +0.28 +6.42% 20:05 09/21 EDT
OPEN
4.250
PREV CLOSE
4.370
HIGH
4.440
LOW
4.100
VOLUME
35.92K
TURNOVER
0
52 WEEK HIGH
15.50
52 WEEK LOW
2.700
MARKET CAP
7.61M
P/E (TTM)
-0.4703
1D
5D
1M
3M
1Y
5Y
Kintara Therapeutics Inc: Prospectus [Rule 424(b)(5)]
Press release · 2d ago
Kintara Therapeutics Non-GAAP EPS of -$9.27
Seeking Alpha · 3d ago
Kintara Therapeutics Inc: Annual report
Press release · 3d ago
Kintara Therapeutics Inc: Current report
Press release · 3d ago
Weekly Report: what happened at KTRA last week (0911-0915)?
Weekly Report · 3d ago
Weekly Report: what happened at KTRA last week (0904-0908)?
Weekly Report · 09/11 10:27
Weekly Report: what happened at KTRA last week (0828-0901)?
Weekly Report · 09/04 20:25
Kintara Therapeutics Inc: Statement of changes in beneficial ownership of securities
Press release · 09/01 22:08
More
About KTRA
Kintara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of new cancer therapies. It is focused on the development of novel cancer therapies for patients with unmet medical needs. Its two candidates include VAL-083 and REM-001. VAL-083 is a novel, validated, deoxyribonucleic acid (DNA)-targeting agent, for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme (GBM) and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer (NSCLC), and diffuse intrinsic pontine glioma (DIPG). REM-001 is a late-stage photodynamic therapy (PDT) for the treatment of cutaneous metastatic breast cancer (CMBC), basal cell carcinoma nevus syndrome (BCCNS), and access graft failure in hemodialysis patients. VAL-083 is being evaluated in all three GBM patient subtypes in the GBM AGILE Study: newly diagnosed methylated MGMT; newly diagnosed unmethylated MGMT, and recurrent.

Webull offers kinds of Kintara Therapeutics Inc stock information, including NASDAQ:KTRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KTRA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KTRA stock methods without spending real money on the virtual paper trading platform.